Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002132363 | SCV002407294 | benign | not provided | 2025-01-29 | criteria provided, single submitter | clinical testing | |
Ce |
RCV002132363 | SCV004142035 | likely benign | not provided | 2023-03-01 | criteria provided, single submitter | clinical testing | DNAH9: BP4, BP7, BS2 |
Breakthrough Genomics, |
RCV002132363 | SCV005254876 | benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV003895817 | SCV004726901 | likely benign | DNAH9-related disorder | 2019-06-12 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |